Email This Article

This Is No Time to Be Buying Pfizer
By Lissa Morgenthaler
10/22/01 - 07:39 AM EDT
The company's fairly valued already, and at least one of its blockbuster drugs, Lipitor, is looking vulnerable.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now. See All

  • Cramer's Daily Booyah!
  • Before the Bell